4.1 Review

A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Hematology

Switching patients in the age of long-acting recombinant products?

Miguel Escobar et al.

EXPERT REVIEW OF HEMATOLOGY (2019)

Article Hematology

Joint disease in haemophilia: Pathophysiology, pain and imaging

L. F. D. van Vulpen et al.

HAEMOPHILIA (2018)

Article Hematology

Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII

M. T. Reding et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

Review Medicine, General & Internal

Treatment adherence in hemophilia

Courtney D. Thornburg et al.

PATIENT PREFERENCE AND ADHERENCE (2017)

Article Hematology

Guidelines for the management of hemophilia

A. Srivastava et al.

HAEMOPHILIA (2013)

Article Medicine, General & Internal

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia

Marilyn J. Manco-Johnson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)